Scientists
at the Center for Infection and Immunity (CII) at Columbia University's Mailman
School of Public Health have discovered abnormal levels
of specific gut bacteria related to chronic fatigue syndrome/myalgic
encephalomyelitis, or ME/CFS, in patients with and without concurrent irritable
bowel syndrome, or IBS. Findings are published in the journal Microbiome.
The
study is among the first to disentangle imbalances in the gut bacteria in
individuals with ME/CFS and IBS. ME/CFS is a complex, debilitating disorder
characterized by extreme fatigue after exertion and other symptoms including
muscle and joint pain, cognitive dysfunction, sleep disturbance, and
orthostatic intolerance. Up to 90 percent of ME/CFS patients also have IBS.
The
researchers followed 50 patients and 50 matched healthy controls recruited at
four ME/CFS clinical sites. They tested for bacterial species in fecal samples,
and for immune molecules in blood samples.
See:
Posted by Dr. Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources